翔宇医疗股价涨5.08%，大成基金旗下1只基金重仓，持有9685股浮盈赚取4.07万元

Group 1 - The core point of the news is that Xiangyu Medical has seen a stock price increase of 5.08%, reaching 86.90 CNY per share, with a trading volume of 5.23 billion CNY and a turnover rate of 3.96%, resulting in a total market capitalization of 139.04 billion CNY [1] - Xiangyu Medical, established on March 20, 2002, and listed on March 31, 2021, specializes in the research, production, and sales of rehabilitation medical devices [1] - The company's main business revenue composition includes rehabilitation therapy equipment at 67.79%, rehabilitation training equipment at 22.13%, operating and accessory products at 5.03%, rehabilitation assessment equipment at 3.72%, and other supplementary products at 1.33% [1] Group 2 - From the perspective of major fund holdings, Dachen Fund has a significant position in Xiangyu Medical, with the Dachen Zhihui Quantitative Multi-Strategy Mixed A Fund (004209) holding 9,685 shares, unchanged from the previous period, accounting for 3.76% of the fund's net value [2] - The Dachen Zhihui Quantitative Multi-Strategy Mixed A Fund was established on March 21, 2017, with a latest scale of 8.77 million CNY, and has achieved a year-to-date return of 4.31% [2] - The fund's one-year return stands at 33.84%, ranking 4,163 out of 8,091 in its category, while the cumulative return since inception is 6.82% [2]